Clinical Trial

Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)

Name: Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC) — clinical trial record (NCT06886360)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Open-label, multi-center, phase III trial. Oral treatment with 1500 mg norucholic acid in Primary Sclerosing cholangitis

Trial Details

NCT Number	NCT06886360
Lead Sponsor	Dr. Falk Pharma GmbH
Conditions	Primary Sclerosing Cholangitis
Enrollment	120 participants
Start Date	2025-03
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-03-20